About   Help   FAQ
Phenotypes associated with this allele
Allele Symbol
Allele Name
Allele ID
Tg(Myh6-ACE2)2Rbre
transgene insertion 2, Roger E Breitbart
MGI:6459903
Summary 1 genotype
Jump to Allelic Composition Genetic Background Genotype ID
tg1
Tg(Myh6-ACE2)2Rbre/0 involves: FVB/N MGI:6459905


Genotype
MGI:6459905
tg1
Allelic
Composition
Tg(Myh6-ACE2)2Rbre/0
Genetic
Background
involves: FVB/N
Find Mice Using the International Mouse Strain Resource (IMSR)
No mouse lines available in IMSR.
See publication links below for author information.
phenotype observed in females
phenotype observed in males
N normal phenotype
mortality/aging
• approximate 30% long-term survival
• 50% of mice die by 5 weeks of age

cardiovascular system
• hearts show rare focal myocyte vacuolization, myofibril splaying, and nuclear enlargement
• hearts show mild focal interstitial fibrosis
• however, hearts are grossly normal without hypertrophy or chamber enlargement, normal ventricular myocardium
• 4-week old mice exhibit non-sustained and sustained ventricular tachycardia
• ventricular tachycardia is initiated after prolonged ventricular pause (following a ventricular premature beat or A-V block) and shows no circadian or activity-related correlation
• programmed stimulation induces ventricular tachycardia in 63% of transgenic mice with none in wild-type mice
• 5 week old mice show no differences in ventricular tachycardia frequency before, during, or after exercise
• 4 of 12 mice that die suddenly show ventricular tachycardia progressing to ventricular fibrillation
• 3 of 8 mice exhibit ventricular premature beats at 3 weeks of age
• all mice show high-grade ventricular ectopy at 4 weeks of age
• ventricular premature beat density increases at slower heart rates associated with high-grade atrioventricular block
• however, beginning at 5 weeks of age, the surviving mice show decreased ventricular ectopy density
• 5 week old mice show no differences in ventricular premature beat before, during, or after exercise
• isoproterenol or atropine treatment reduces ventricular premature beat frequency
• all mice at 3 weeks of age exhibit complete atrial-His (AH) block
• by 6-9 months of age, surviving mice have one-to-one A-V conduction, albeit with prolonged AH and AV node-effective refractory periods
• all mice develop first-degree atrioventricular (AV) block by 2 weeks of age
• by 3 weeks, all mice progress to complete atrioventricular block
• however, beginning at 5 weeks of age, the surviving mice show improved atrioventricular conduction
• all mice exhibit prolonged PR at 2 weeks of age
• mice at 3 weeks of age exhibit increased atrial-effective refractory period and ventricular-effective refractory period
• all mice at 3 weeks of age exhibit prolonged His-ventricular intervals
• all mice show mild QRS prolongation at 2 weeks of age
• lower mean arterial blood pressure at baseline and throughout the dobutamine dose range

liver/biliary system
• focal apoptosis and necrosis in centrilobular areas of the liver

muscle
• hearts show rare focal myocyte vacuolization, myofibril splaying, and nuclear enlargement

nervous system
• focal apoptosis and necrosis in CA1/CA2 regions of the hippocampus

cellular
• hearts show mild focal interstitial fibrosis
• however, hearts are grossly normal without hypertrophy or chamber enlargement, normal ventricular myocardium





Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
11/12/2024
MGI 6.24
The Jackson Laboratory